Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
109 participants
INTERVENTIONAL
2010-11-30
2011-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Certoparin
Certoparin
Certoparin
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Certoparin
Certoparin
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients requiring anticoagulation therapy during hemodialysis
* Written informed consent
Exclusion Criteria
* Genetic abnormality or disease of clotting system
* Prior major surgery or bleeding
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Novartis
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Novartis Pharmaceuticals
Role: STUDY_DIRECTOR
Novartis Pharmaceuticals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Novartis Investigative Site Darmstadt
Darmstadt, , Germany
Novartis Investigative Site Elsenfeld
Elsenfeld, , Germany
Novartis Investigative Site Flensburg
Flensburg, , Germany
Novartis Investigative Site Heringen
Heringen, , Germany
Novartis Investigative Site Hoyerswerda,
Hoyerswerda, , Germany
Novartis Investigative Site Kronach
Kronach, , Germany
Novartis Investigative Site Magdeburg
Magdeburg, , Germany
Novartis Investigative Site München
München, , Germany
Novartis Investigative Site Münster
Münster, , Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Dorsch O, Krieter DH, Lemke HD, Fischer S, Melzer N, Sieder C, Bramlage P, Harenberg J. A multi-center, prospective, open-label, 8-week study of certoparin for anticoagulation during maintenance hemodialysis--the membrane study. BMC Nephrol. 2012 Jun 28;13:50. doi: 10.1186/1471-2369-13-50.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CMEX839BDE06
Identifier Type: -
Identifier Source: org_study_id